Table 1.
Study’s characteristics between the patients and healthy controls.
| Characteristics | Categories | Cases | Controls | ||
|---|---|---|---|---|---|
| n = 734 | Mean ± SD | n = 96 | Mean ± SD | ||
| Age (Year)1 | 20–40 | 25 (3.41%) | 61.20 ± 9.82 | 32 (33.33%) | 48.24 ± 16.65 |
| 41–60 | 283 (38.56%) | 39 (40.63%) | |||
| 61–80 | 411 (56.00%) | 23 (23.96%) | |||
| 81–100 | 8 (1.09%) | 2 (2.08%) | |||
| Gender2 | Male | 499 (67.99%) | – | 65 (67.71%) | – |
| Female | 235 (32.02%) | – | 31 (32.30%) | – | |
| Type of cancer2 | SCLC | 157 (21.39%) | – | – | – |
| Adenocarcinoma | 356 (48.50%) | – | – | – | |
| Squamous cell carcinoma | 159 (21.66%) | – | – | – | |
| Large cell carcinoma | 17 (2.32%) | – | – | – | |
| Disease stage2 | I–II | 35 (4.77%) | – | – | – |
| III–IV | 213 (29.10%) | – | – | – | |
| Chemotherapy protocol2 | Treatment naive | 110 (14.99%) | |||
| CTx | 414 (56.40%) | ||||
| CTx + RTx | 185 (25.20%) | ||||
1
Mean ± SD for quantitative variables.
2
Number (Relative Frequency %) for the categorical variable.